Cargando…
Treatment of isoniazid-resistant pulmonary tuberculosis
BACKGROUND: Although resistance to isoniazid (INH) is the most common form of drug resistance seen among Mycobacterium tuberculosis isolates, there have been few studies on the efficacy and optimal duration of treatment for patients with INH-resistant tuberculosis (TB). METHODS: We evaluated retrosp...
Autores principales: | Kim, Yee Hyung, Suh, Gee Young, Chung, Man Pyo, Kim, Hojoong, Kwon, O Jung, Lim, Seong Yong, Lim, Si Young, Koh, Won-Jung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2245946/ https://www.ncbi.nlm.nih.gov/pubmed/18211720 http://dx.doi.org/10.1186/1471-2334-8-6 |
Ejemplares similares
-
Six-month Therapy with Aerosolized Interferon-γ for Refractory Multidrug-Resistant Pulmonary Tuberculosis
por: Koh, Won-Jung, et al.
Publicado: (2004) -
Diagnosis and Treatment of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists in Korea
por: Yun, Jong Wook, et al.
Publicado: (2007) -
Usefulness of open lung biopsy in mechanically ventilated patients with undiagnosed diffuse pulmonary infiltrates: influence of comorbidities and organ dysfunction
por: Lim, Seong Yong, et al.
Publicado: (2007) -
The Value of Routinely Culturing for Tuberculosis During Bronchoscopies in an Intermediate Tuberculosis-Burden Country
por: Kim, Myung Hoon, et al.
Publicado: (2007) -
Drug Resistance Rates of Mycobacterium tuberculosis at a Private Referral Center in Korea
por: Choi, Jae Chol, et al.
Publicado: (2007)